Literature DB >> 27816535

Functional analysis of four single (RGDWL, RGDWM, RGDWP, RGDMN) and two double (RGDNM, RGDMP) mutants: The importance of methionine (M) in the functional potency of recombinant mojastin (r-Moj).

Daniel A Gutierrez1, Ana S Aranda1, David A R Carrillo1, Melissa A Koshlaychuk1, Elda E Sanchez2, Sara E Lucena2, Julio G Soto3.   

Abstract

We have demonstrated in previous studies that a single amino acid change can alter the activity of the recombinant disintegrin r-Moj. In this study, four r-Moj recombinants containing single mutations (r-Moj-WL, r-Moj-WM, r-Moj-WP, r-Moj-MN) and two containing double mutations (r-Moj-MP and r-Moj-NM) at the binding loop were produced, purified, and tested. All r-Moj-W_, r-Moj-M_, and r-Moj-NM mutant peptides inhibited platelet aggregation at higher potency than r-Moj-D_ mutants. Five of the seven r-Moj peptides inhibited angiogenesis at different levels. Two of the mutant peptides with a methionine at the second position carboxyl of the RGD (r-Moj-WM and r-Moj-NM) were the strongest angiogenesis inhibitors, with r-Moj-WM being the most potent. Recombinant r-Moj-MP and r-Moj-WN failed to inhibit angiogenesis. Only the r-Moj-MP mutant peptide induced apoptosis of SK-Mel-28 cells significantly (p = 0.001). This was confirmed by chromatin condensation. Proliferation of SK-Mel-28 cells was inhibited at high levels (>70%) by all r-Moj mutant peptides. Recombinant r-Moj-MN and r-Moj-WN failed to inhibit cell migration significantly (p > 0.5). Recombinant r-Moj-NM was the strongest cell migration inhibitor (98% ± 0.69), followed by r-Moj-MP (80% ± 2.87), and r-Moj-WM (61.8% ± 5.45). The lowest inhibitor was r-Moj-WL (50% ± 12.16). Our functional data suggest that the most potent r-Moj disintegrins contain a methionine in the first or the second position carboxyl to the RGD. Copyright Â
© 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Angiogenesis; Apoptosis; Binding-loop mutants; Cell migration; Cell proliferation; Melanoma cell line; Mojastin; Recombinant disintegrin

Mesh:

Substances:

Year:  2016        PMID: 27816535      PMCID: PMC5175404          DOI: 10.1016/j.toxicon.2016.11.002

Source DB:  PubMed          Journal:  Toxicon        ISSN: 0041-0101            Impact factor:   3.033


  33 in total

1.  Pro-apoptotic signaling pathway activated by echistatin in GD25 cells.

Authors:  Elena Alimenti; Simona Tafuri; Antonio Scibelli; Danila D'Angelo; Laura Manna; Luigi Michele Pavone; M Antonietta Belisario; Norma Staiano
Journal:  Biochim Biophys Acta       Date:  2004-07-23

2.  Molecular evolution of PIII-SVMP and RGD disintegrin genes from the genus Crotalus.

Authors:  Julio G Soto; Stephanie A White; Steven R Reyes; Renato Regalado; Elda E Sanchez; John C Perez
Journal:  Gene       Date:  2006-10-05       Impact factor: 3.688

3.  Accutin, a new disintegrin, inhibits angiogenesis in vitro and in vivo by acting as integrin alphavbeta3 antagonist and inducing apoptosis.

Authors:  C H Yeh; H C Peng; T F Huang
Journal:  Blood       Date:  1998-11-01       Impact factor: 22.113

4.  Positional importance of Pro53 adjacent to the Arg49-Gly50-Asp51 sequence of rhodostomin in binding to integrin alphaIIbbeta3.

Authors:  C P Chang; J C Chang; H H Chang; W J Tsai; S J Lo
Journal:  Biochem J       Date:  2001-07-01       Impact factor: 3.857

5.  Functional characterization of six aspartate (D) recombinant mojastin mutants (r-Moj): A second aspartate amino acid carboxyl to the RGD in r-Moj-D_ peptides is not sufficient to induce apoptosis of SK-Mel-28 cells.

Authors:  Carla J Ramos; Daniel A Gutierrez; Ana S Aranda; Melissa A Koshlaychuk; David A Carrillo; Rafael Medrano; Terri D McBride; Andrew U; Stephanie M Medina; Melissa C Lombardo; Sara E Lucena; Elda E Sanchez; Julio G Soto
Journal:  Toxicon       Date:  2016-04-20       Impact factor: 3.033

6.  Structural requirements of echistatin for the recognition of alpha(v)beta(3) and alpha(5)beta(1) integrins.

Authors:  I Wierzbicka-Patynowski; S Niewiarowski; C Marcinkiewicz; J J Calvete; M M Marcinkiewicz; M A McLane
Journal:  J Biol Chem       Date:  1999-12-31       Impact factor: 5.157

7.  The snake venom disintegrin salmosin induces apoptosis by disassembly of focal adhesions in bovine capillary endothelial cells.

Authors:  Sung-Yu Hong; Hyeryung Lee; Weon-Kyoo You; Kwang-Hoe Chung; Doo-Sik Kim; Kiwon Song
Journal:  Biochem Biophys Res Commun       Date:  2003-03-14       Impact factor: 3.575

8.  Contortrostatin, a dimeric disintegrin from Agkistrodon contortrix contortrix, inhibits angiogenesis.

Authors:  Q Zhou; M T Nakada; C Arnold; K Y Shieh; F S Markland
Journal:  Angiogenesis       Date:  1999       Impact factor: 9.596

9.  Disintegrin causes proteolysis of beta-catenin and apoptosis of endothelial cells. Involvement of cell-cell and cell-ECM interactions in regulating cell viability.

Authors:  Wen-Bin Wu; Hui-Chin Peng; Tur-Fu Huang
Journal:  Exp Cell Res       Date:  2003-05-15       Impact factor: 3.905

Review 10.  Antitumoral activity of snake venom proteins: new trends in cancer therapy.

Authors:  Leonardo A Calderon; Juliana C Sobrinho; Kayena D Zaqueo; Andrea A de Moura; Amy N Grabner; Maurício V Mazzi; Silvana Marcussi; Auro Nomizo; Carla F C Fernandes; Juliana P Zuliani; Bruna M A Carvalho; Saulo L da Silva; Rodrigo G Stábeli; Andreimar M Soares
Journal:  Biomed Res Int       Date:  2014-02-13       Impact factor: 3.411

View more
  1 in total

Review 1.  Recombinant and Chimeric Disintegrins in Preclinical Research.

Authors:  Victor David; Barbara Barbosa Succar; João Alfredo de Moraes; Roberta Ferreira Gomes Saldanha-Gama; Christina Barja-Fidalgo; Russolina Benedeta Zingali
Journal:  Toxins (Basel)       Date:  2018-08-07       Impact factor: 4.546

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.